Cargando…

Altered expression of Tumor Necrosis Factor Alpha -Induced Protein 3 correlates with disease severity in Ulcerative Colitis

Ulcerative colitis (UC), an inflammatory disorder of the colon arises from dysregulated immune response towards gut microbes. Transcription factor NFκB is a major regulatory component influencing mucosal inflammation. We evaluated expression of Tumor Necrosis Factor Alpha Induced Protein3 (TNFAIP3),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Majumdar, Ishani, Ahuja, Vineet, Paul, Jaishree
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572729/ https://www.ncbi.nlm.nih.gov/pubmed/28842689 http://dx.doi.org/10.1038/s41598-017-09796-9

Ejemplares similares

MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients
por: Valmiki, Swati, et al.
Publicado: (2017)

Site-Specific MicroRNA Expression May Lead to Different Subtypes in Ulcerative Colitis
por: Ranjha, Raju, et al.
Publicado: (2015)

Association of miR-196a-2 and miR-499 variants with ulcerative colitis and their correlation with expression of respective miRNAs
por: Ranjha, Raju, et al.
Publicado: (2017)

Correction: Association of miR-196a-2 and miR-499 variants with ulcerative colitis and their correlation with expression of respective miRNAs
por: Ranjha, Raju, et al.
Publicado: (2017)

Frequency of single nucleotide polymorphisms in NOD1 gene of ulcerative colitis patients: a case-control study in the Indian population
por: Verma, Ravi, et al.
Publicado: (2009)

Association of TLR5 Gene Polymorphisms in Ulcerative Colitis Patients of North India and Their Role in Cytokine Homeostasis
por: Meena, Naresh Kumar, et al.
Publicado: (2015)

Eosinophilic Gastroenteritis in an Ulcerative Colitis Patient During Treatment with Tumor Necrosis Factor-alpha Antagonist
por: Hayashida, Sho, et al.
Publicado: (2020)

Body Composition in Crohn's Disease and Ulcerative Colitis: Correlation with Disease Severity and Duration
por: Yadav, Dawesh P., et al.
Publicado: (2017)

Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha use
por: Kang, Ho Suk, et al.
Publicado: (2019)

Altered Salivary Alpha-Amylase Secretion in Patients with Ulcerative Colitis
por: Xu, Zhuoni, et al.
Publicado: (2018)

T cell lymphoproliferative disorders associated with anti-tumor necrosis factor alpha antibody therapy for ulcerative colitis: literature summary
por: Schmidt, Lindsay A., et al.
Publicado: (2009)

Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients
por: Berends, Sophie E., et al.
Publicado: (2019)

Tumor Necrosis Factor Alpha Blocking Agents as Treatment for Ulcerative Colitis Intolerant or Refractory to Conventional Medical Therapy: A Meta-Analysis
por: Lv, Ruxi, et al.
Publicado: (2014)

Tumor Necrosis Factor-Alpha Inhibitor-Associated Psoriatic Alopecia in a Patient with Ulcerative Colitis: A Case Report and Review of the Literature
por: Jeong, Kyung Muk, et al.
Publicado: (2021)

Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis
por: Kerur, Basavaraj, et al.
Publicado: (2017)

Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis
por: Kamat, Nagesh, et al.
Publicado: (2022)

Sulforaphane alter the microbiota and mitigate colitis severity on mice ulcerative colitis induced by DSS
por: Zhang, Yan, et al.
Publicado: (2020)

A case of lupus erythematosus profundus with severe ulceration that responded to tumor necrosis factor-alpha--blocking agents
por: Nakagomi, Daiki
Publicado: (2021)

Correlation of Biomarkers with Endoscopic Score: Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in Patients with Ulcerative Colitis in Remission
por: Pop, Corina Silvia, et al.
Publicado: (2020)

Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis
por: Lukin, Dana, et al.
Publicado: (2020)

Association between serum tumor necrosis factor-alpha level and the efficacy of infliximab for refractory pouchitis after restorative proctocolectomy in patients with ulcerative colitis
por: Uchino, Motoi, et al.
Publicado: (2018)

Immune‐mediated inflammatory diseases of the gastrointestinal tract: Beyond Crohn's disease and ulcerative colitis
por: Vuyyuru, Sudheer K, et al.
Publicado: (2022)

Familial aggregation of inflammatory bowel disease in patients with ulcerative colitis
por: Gupta, Akshita, et al.
Publicado: (2017)

Colorectal cancer severity and survival in correlation with tumour necrosis factor-alpha
por: Stanilov, Noyko, et al.
Publicado: (2014)

Gut mucosal virome alterations in ulcerative colitis
por: Zuo, Tao, et al.
Publicado: (2019)

Radionuclide tumor necrosis factor-alpha activity in herniated lumbar disc correlates with severe leg pain
por: Andrade, Pablo, et al.
Publicado: (2020)

Correlation between fecal calprotectin, ulcerative colitis endoscopic index of severity and clinical outcome in patients with acute severe colitis
por: Ma, Rong, et al.
Publicado: (2020)

Impact of gut Microbiome alteration in Ulcerative Colitis patients on disease severity and outcome
por: Basha, Osama Mohammed, et al.
Publicado: (2022)

Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy
por: Baird, Angela C, et al.
Publicado: (2016)

Lesson from Real-World Experience: Optimal Treatment with Anti-Tumor Necrosis Factor for Ulcerative Colitis
por: Chun, Jaeyoung
Publicado: (2021)

Sirolimus (Rapamycin) Induced Mucosal Healing in Anti-Tumor Necrosis Factor Refractory Pediatric Ulcerative Colitis
por: Kellermayer, Richard, et al.
Publicado: (2022)

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)
por: Travis, Simon P L, et al.
Publicado: (2011)

Role of Eosinophils and Tumor Necrosis Factor Alpha in Interleukin-25-Mediated Protection from Amebic Colitis
por: Noor, Zannatun, et al.
Publicado: (2017)

Myeloid cell influx into the colonic epithelium is associated with disease severity and non-response to anti-Tumor Necrosis Factor Therapy in patients with Ulcerative Colitis
por: Jha, Divya, et al.
Publicado: (2023)

384 Alterations in the fungal microbiome in ulcerative colitis
por: Jangi, Sushrut, et al.
Publicado: (2023)

High mucosal cytomegalovirus DNA helps predict adverse short-term outcome in acute severe ulcerative colitis
por: Jain, Saransh, et al.
Publicado: (2021)

Dysregulation of GABAergic Signalling Contributes in the Pathogenesis of Diarrhea-predominant Irritable Bowel Syndrome
por: Aggarwal, Surbhi, et al.
Publicado: (2018)

Comparison of the Mayo Endoscopy Score and the Ulcerative Colitis Endoscopy Index of Severity and the Ulcerative Colitis Colonoscopy Index of Severity
por: Belvis Jiménez, María, et al.
Publicado: (2021)

Post-transcriptional regulation of tumor necrosis factor alpha expression
por: Brooks, S, et al.
Publicado: (2004)

Ulcerative Colitis-Symptom Questionnaire: Valid for Use in Adults with Moderately to Severely Active Ulcerative Colitis
por: Panes, Julian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lciapb05s3pdkukjhqe1ccaj8b